Hyperion DeFi Insider Buys Spark Optimism Amid Promising nAMD Therapy Pipeline
Hyperion DeFi insider buys boost confidence as Phase II results show promising visual‑acuity gains for nAMD therapy, hinting at future FDA approval and market impact.
4 minutes to read